{"name":"Lai-ping Zhong","slug":"lai-ping-zhong","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"albumin paclitaxel, cispatin, tislelizumab","genericName":"albumin paclitaxel, cispatin, tislelizumab","slug":"albumin-paclitaxel-cispatin-tislelizumab","indication":"Non-small cell lung cancer, gastric cancer, esophageal cancer","status":"phase_3"}]}],"pipeline":[{"name":"albumin paclitaxel, cispatin, tislelizumab","genericName":"albumin paclitaxel, cispatin, tislelizumab","slug":"albumin-paclitaxel-cispatin-tislelizumab","phase":"phase_3","mechanism":"Albumin paclitaxel is a targeted chemotherapy drug that delivers paclitaxel directly to tumors, while tislelizumab is a PD-1 inhibitor that blocks the PD-1/PD-L1 pathway to enhance anti-tumor immune response, and cisplatin is a platinum-based chemotherapy drug that interferes with DNA replication.","indications":["Non-small cell lung cancer, gastric cancer, esophageal cancer"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}